DGNMFDiagnamed Holdings Corp.

About Diagnamed Holdings Corp. (DGNMF)

Diagnamed Holdings Corp. (DGNMF) is a Health Information Services company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the OTCQB tier.

DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a life sciences company focused on molecular hydrogen and AI diagnostics for brain health. DiagnaMed is exploring the medical use of hydrogen for brain health conditions, such as neurological and mental health disorders. In addition, the Company is commercializing BRAIN AGE® Brain Health AI Platform, a world-first consumer brain health and wellness AI solution that estimates brain age and provides a brain health score. Visit DiagnaMed.com.

Products and services

DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a life sciences company focused on molecular hydrogen and AI diagnostics for brain health. DiagnaMed is exploring the medical use of hydrogen for brain health conditions, such as neurological and mental health disorders. In addition, the Company is commercializing BRAIN AGE® Brain Health AI Platform, a world-first consumer brain health and wellness AI solution that estimates brain age and provides a brain health score.

DGNMF key facts

Ticker symbol

DGNMF

Market tier

OTCQB

Sector

Healthcare

Industry

Health Information Services

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

2021

Employees

2

Estimated market cap

$1.66M (as of May 9, 2025)

Shares outstanding

96,658,973

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

9/30

Latest filing

Interim Financial Report (Dec 31, 2024)

Diagnamed Holdings Corp. leadership

• Fabio Andrea Chianelli — CEO, President
• Jing Peng — CFO
• Andrew Charles Newbury — Company Secretary

Explore more: Health Information Services stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with D